Welcome to Clearview-360, the leading-edge AI-powered solution designed to revolutionize eye screening for diabetic retinopathy. With Clearview-360, we combine the power of artificial intelligence (AI) with the expertise of ophthalmologists to deliver rapid and accurate diagnoses. Our advanced AI algorithms analyze retinal images with remarkable precision, enabling early detection and proactive management of diabetic retinopathy.


ClearView-360 AI-assisted Diagnosis

Clearview-360 brings efficiency and reliability to the screening process. Our AI technology assists ophthalmologists in interpreting retinal images, providing them with invaluable insights for confident decision-making.

By incorporating Clearview-360 into your workflow, you can significantly enhance diagnostic accuracy and streamline patient care. What sets Clearview-360 apart is its explainable report, which offers transparency and clarity in the diagnostic process. We understand the importance of trust and understanding, which is why we provide detailed explanations of our AI-generated results. This ensures that both healthcare professionals and patients have a comprehensive understanding of the diagnosis and can make informed decisions regarding treatment options.

With Clearview-360, you can stay at the forefront of diabetic retinopathy care. Our product is optimized for AI eye-screening, leveraging the latest advancements in artificial intelligence to deliver unparalleled performance in detecting this specific condition. We are committed to empowering ophthalmologists and healthcare providers with the tools they need to provide the best possible care for patients with diabetic retinopathy.

Experience the future of AI eye screening and elevate the standard of care for diabetic retinopathy with Clearview-360. Start optimizing your screening process today and join the forefront of innovation in ophthalmic diagnostics.

What People  Say

Ophthalytics has completely transformed the way I screen for ophthalmic conditions. With its advanced AI technology, it offers accurate and efficient detection of diabetic retinopathy, even in its early stages. The system's speed and accuracy are unparalleled, making it the fastest and most accurate resource for DR assessment. The user-friendly interface allows for quick and efficient evaluations of patient data, enhancing the overall screening process. Ophthalytics has truly been a game-changer in improving early detection and enabling timely interventions to prevent vision loss.
Dr. Emily Thompson
At our reading center, implementing Ophthalytics has revolutionized our screening capabilities. Its camera-agnostic nature allows us to seamlessly work with any camera, ranging from 30-degree to 200-degree field of view. This flexibility has greatly enhanced our workflow, enabling efficient assessments of patients. Ophthalytics stands out for its early detection capabilities, enabling us to detect diabetic retinopathy even in its mild stages. With the system's quick and accurate results, we can serve more patients effectively, saving both time and resources. Ophthalytics has proven to be an invaluable asset in our fight against diabetic retinopathy
Reading Center (John Davis)
Reading Center Manager
Ophthalytics has become an indispensable tool in my practice as a primary care physician. Its ability to detect diabetic retinopathy at early stages is truly remarkable. With Ophthalytics, I can quickly and accurately assess my patients, allowing for timely interventions to prevent vision loss. The user-friendly interface makes it easy to evaluate patient data, facilitating efficient screenings. Ophthalytics has not only saved costs on infrastructure upgrades but also allowed me to serve a larger number of patients effectively. It has undoubtedly improved the quality of care I provide to my patients
Dr. Sarah Patel
Primary Care Physician (PCP)